Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2026-03-01 @ 8:12 PM
Study NCT ID:
NCT02858206
Status:
UNKNOWN
Last Update Posted:
2019-07-26
First Post:
2016-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
Sponsor:
Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
None
Primary Completion Date:
2019-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-11
Completion Date Type:
ESTIMATED
First Submit Date:
2016-07-30
First Submit QC Date:
None
Study First Post Date:
2016-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-25
Last Update Post Date:
2019-07-26
Last Update Post Date Type:
ACTUAL